Plain-English translation of NCT07044557 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether it is safe to skip dexamethasone โ a steroid medication commonly given before and after brain surgery โ in patients with cancer that has spread to the brain. Researchers want to understand whether patients can undergo surgery to remove these brain tumors without this steroid, and whether doing so causes any harm or complications.
Steroids like dexamethasone have been used routinely during brain surgery for many years, but doctors are now asking whether this medication is truly necessary for every patient. By studying whether the treatment can be safely withheld, researchers hope to reduce unnecessary medication exposure and understand which patients actually benefit from receiving it.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you will undergo brain surgery to remove the tumor without receiving dexamethasone before or after the operation. Doctors will monitor you closely after surgery and collect information about how you recover, including blood tests to check for certain side effects. You will be followed from the time of surgery until you start other cancer treatments, with visits to assess your condition and gather information about how well you are doing.
AI-generated summary from trial data ยท Jul 3, 2026 ยท Not medical advice
United States
Sponsor
University of Louisville
Enrollment target
~35 participants
Started
August 2026
Primary completion
October 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
A Mistry, MD
University of Louisville
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.